# Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members

> **NCT04813497** · NA · COMPLETED · sponsor: **Grand Hôpital de Charleroi** · enrollment: 4000 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** Serology to determine SARS-CoV-2 infection

## Key facts

- **NCT ID:** NCT04813497
- **Lead sponsor:** Grand Hôpital de Charleroi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-05
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 4000 (ACTUAL)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04813497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04813497, "Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04813497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*